(Q47267750)

12 January 2018

title

Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia. (English)

1 reference

12 January 2018

1 reference

12

1 reference

12 January 2018

Christine J Harrison

13

1 reference

12 January 2018

Christine Ragu

object named as

C Ragu

5

0 references

Florence Nguyen-Khac

object named as

F Nguyen-Khac

14

0 references

Patrice Dubreuil

object named as

P Dubreuil

15

0 references

author name string

E Chapiro

1

1 reference

12 January 2018

L Russell

2

1 reference

12 January 2018

E Lainey

3

1 reference

12 January 2018

S Kaltenbach

4

1 reference

12 January 2018

V Della-Valle

6

1 reference

12 January 2018

K Hanssens

7

1 reference

12 January 2018

E A Macintyre

8

1 reference

12 January 2018

I Radford-Weiss

9

1 reference

12 January 2018

E Delabesse

10

1 reference

12 January 2018

H Cavé

11

1 reference

12 January 2018

O A Bernard

16

1 reference

12 January 2018

publication date

12 November 2009

1 reference

12 January 2018

published in

Leukemia

1 reference

12 January 2018

volume

24

1 reference

12 January 2018

page(s)

642-645

1 reference

12 January 2018

issue

3

1 reference

12 January 2018

https://scigraph.springernature.com/pub.10.1038/leu.2009.231

exact match

0 references

cites work

Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.231

Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.231

Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.231

Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.231

Thymic stromal lymphopoietin in normal and pathogenic T cell development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.231

Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.231

Miscreant myeloproliferative disorder stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.231

JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.231

Homodimerization and constitutive activation of the erythropoietin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.231

Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.231

Human thymic stromal lymphopoietin preferentially stimulates myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.231

Molecular cloning of a human novel type I cytokine receptor related to delta1/TSLPR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.231

Activating mutations in human acute megakaryoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.231

21 January 2018

Identifiers

DOI

10.1038/LEU.2009.231

1 reference

12 January 2018

PubMed ID

19907440

1 reference

12 January 2018